Related Experiment Videos

Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced

M-V Clément1, J L Hirpara, S Pervaiz

  • 11Department of Biochemistry, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260, Singapore.

Insights

Bcl-2 inhibits early cell acidification during apoptosis. Reducing superoxide levels enhances cancer cell sensitivity to apoptosis, suggesting a switch from mitochondria-dependent to independent death signaling for drug treatment.

Area of Science:

  • Cellular Biology
  • Apoptosis Signaling
  • Cancer Research

Background:

  • Two mechanisms of early cytosolic acidification in apoptosis are known: caspase 8 activation and mitochondria-derived hydrogen peroxide.
  • Bcl-2 protein is a key regulator of apoptosis, often overexpressed in cancer cells.

Purpose of the Study:

  • To investigate the role of Bcl-2 in regulating cytosolic acidification during apoptosis.
  • To explore the interplay between superoxide levels, Bcl-2, and apoptotic pathways.

Main Methods:

  • Overexpression of Bcl-2 in CEM leukemia cells.
  • Inhibition of beta-nicotinamide adenine dinucleotide phosphate oxidase and Rac1 signaling.
  • Assessment of caspase 8 activation, cytosolic pH, and apoptosis sensitivity.

Main Results:

  • Bcl-2 inhibits both known mechanisms of early cytosolic acidification during apoptosis.
  • Bcl-2 overexpression slightly elevates constitutive superoxide anion and pH.
  • Decreasing superoxide levels significantly increases sensitivity to apoptosis via enhanced caspase 8 activation, independent of caspase 9 or cytochrome c.

Conclusions:

  • Bcl-2 influences apoptotic signaling by modulating cytosolic acidification and superoxide levels.
  • A mechanism exists for switching apoptotic pathways from mitochondria-dependent to independent signaling.
  • Targeting superoxide levels could sensitize Bcl-2-expressing cancer cells to apoptosis, aiding drug treatment strategies.

Related Concept Videos